US signs $1bn order for GSK, Vir’s COVID-19 antibodyThe US has made a sizeable order for GlaxoSmithKline and Vir Biotechnology’s antibody-based COVID-19 treatment sotrovimab said to Share XUS signs $1bn order for GSK, Vir’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-signs-1bn-order-for-gsk-virs-covid-19-antibody/
